BiomX PHGE Stock
BiomX Price Chart
BiomX PHGE Financial and Trading Overview
| BiomX stock price | 0.87 USD |
| Previous Close | 1.26 USD |
| Open | 1.13 USD |
| Bid | 1.04 USD x 60000 |
| Ask | 1.05 USD x 70000 |
| Day's Range | 1.01 - 1.16 USD |
| 52 Week Range | 0.36 - 14.71 USD |
| Volume | 986.94K USD |
| Avg. Volume | 5.78M USD |
| Market Cap | 10.55M USD |
| Beta (5Y Monthly) | 1.029 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -37.05 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PHGE Valuation Measures
| Enterprise Value | 28M USD |
| Trailing P/E | N/A |
| Forward P/E | -0.1730449 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -1.331 |
Trading Information
BiomX Stock Price History
| Beta (5Y Monthly) | 1.029 |
| 52-Week Change | -89.074% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 14.71 USD |
| 52 Week Low | 0.36 USD |
| 50-Day Moving Average | 1.93 USD |
| 200-Day Moving Average | 5.53 USD |
PHGE Share Statistics
| Avg. Volume (3 month) | 5.78M USD |
| Avg. Daily Volume (10-Days) | 35.03M USD |
| Shares Outstanding | 10.15M |
| Float | 7.8M |
| Short Ratio | 0.43 |
| % Held by Insiders | 27.64% |
| % Held by Institutions | 5.92% |
| Shares Short | 197.53K |
| Short % of Float | 2.25% |
| Short % of Shares Outstanding | 1.94% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:19 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -62.51% |
| Return on Equity (ttm) | -403.76% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -21043500 USD |
| Net Income Avi to Common (ttm) | -47765000 USD |
| Diluted EPS (ttm) | -37.05 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.17M USD |
| Total Cash Per Share (mrq) | 0.12 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 1.244 |
| Book Value Per Share (mrq) | -12.499 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -23092000 USD |
| Levered Free Cash Flow (ttm) | -14990500 USD |
Profile of BiomX
| Country | United States |
| State | DE |
| City | Dover |
| Address | 850 New Burton Road |
| ZIP | 19904 |
| Phone | N/A |
| Website | https://www.biomx.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 20 |
BiomX Inc., a clinical-stage biopharmaceutical company, develops phage-based therapies using natural and engineered phage technologies designed to target and kill specific harmful bacteria associated with chronic diseases. The company's phage-based therapies include fixed cocktail therapy, which involves developing a single product containing a fixed number of selected phages to cover a range of bacterial strains; and personalized therapy, which involves developing a large library of phages from which single optimal phages are personally matched to treat specific patients. It develops BX011, a fixed multi-phage cocktail, which is in Phase 2a trial for the treatment of diabetic foot infections; and BX211, a phage therapy, which is in Phase 2 trial for the treatment of diabetic foot osteomyelitis. BiomX Inc. was founded in 2015 and is based in Dover, Delaware.
Q&A For BiomX Stock
What is a current PHGE stock price?
BiomX PHGE stock price today per share is 0.87 USD.
How to purchase BiomX stock?
You can buy PHGE shares on the NYSE American exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BiomX?
The stock symbol or ticker of BiomX is PHGE.
Which industry does the BiomX company belong to?
The BiomX industry is Biotechnology.
How many shares does BiomX have in circulation?
The max supply of BiomX shares is 10.15M.
What is BiomX Price to Earnings Ratio (PE Ratio)?
BiomX PE Ratio is now.
What was BiomX earnings per share over the trailing 12 months (TTM)?
BiomX EPS is -37.05 USD over the trailing 12 months.
Which sector does the BiomX company belong to?
The BiomX sector is Healthcare.